(Q43038391)

12 November 2017

title

Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

F T Aweeka

1

1 reference

12 November 2017

M Kang

2

1 reference

12 November 2017

J-Y Yu

3

1 reference

12 November 2017

P Lizak

4

1 reference

12 November 2017

B Alston

5

1 reference

12 November 2017

R T Chung

6

1 reference

12 November 2017

AIDS Clinical Trials Group 5092s Study Team

7

1 reference

12 November 2017

publication date

1 July 2007

1 reference

12 November 2017

1 reference

12 November 2017

volume

8

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

288-294

1 reference

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00472.X

Molecular targets for AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00472.X

Ribavirin antagonizes the effect of azidothymidine on HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00472.X

Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00472.X

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00472.X

Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00472.X

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00472.X

Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00472.X

10.1111/J.1468-1293.2007.00472.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference